F2 Ventures

F2 Ventures

A venture capital and private equity firm focused on investing in the biotechnology sector.

F2 Ventures is a venture capital and private equity firm focused on investing in the biotechnology sector that was founded in 2002 and is headquartered in London, England. F2 Ventures also has an office in Geneva, Switzerland.

Investments

Notable investments made by F2 Venture partners include; AlloVir (series A and series B), TCR2 (series B), Cullinan Oncology (series A), iPrice Group (seed round), Clinical Link (venture round), Chiasma (sereis E), ProterixBio (sereis C and series D), and Chiasma (series C).

Timeline

Funded Companies

Company
Description
Industry
Website
Location
AlloVir

AlloVir (formerly ViraCyte) is a company that develops cell therapies for patients suffering from life-threatening virus-associated diseases.

Biotechnology
Houston
TCR2 Therapeutics

TCR2 Therapeutics is a biotechnology company developing T cell hematologic cancer immunotherapies.

Biotechnology
Cambridge, Massachusetts
Cullinan Oncology

Cullinan Oncology is a Cambridge, Massachusetts-based company.

Cambridge, Massachusetts
TriNetX

TriNetX is a Cambridge, Massachusetts-based company.

Cambridge, Massachusetts
4 Results
Page 1 of 1
Results per page:
Powered by Golden Research Engine

People

Name
Role
LinkedIn

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.